Dexcom G7 FDA Warning Lawsuit: 2026 Update and Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

The Dexcom G7 FDA warning lawsuit is one of the biggest medical device legal battles heading into 2026. The FDA has flagged the Dexcom G7 continuous glucose monitor for serious safety issues, and patients are now filing claims.

If you relied on this device to manage your diabetes, you need to know what went wrong. Sensor failures, wildly inaccurate glucose readings, and dangerous malfunctions have been tied to real injuries and, in some cases, deaths.

You might also find this useful — e.l.f. Right of Publicity Lawsuit 2026: Settlement Guide

Thousands of adverse events sit in the FDA’s MAUDE database right now. That number keeps growing. This article breaks down every detail you need: the FDA warnings, the recall history, who qualifies, how to file, deadlines, and what kind of settlement money is on the table in 2026.

You’ll find timelines, tables, and straight answers. No fluff. No filler. Just the facts that matter to your case.

Dexcom G7 FDA Warning Lawsuit Overview

The Dexcom G7 FDA warning lawsuit refers to a growing wave of legal claims filed against Dexcom Inc. by patients who were harmed by the company’s G7 continuous glucose monitoring system. These lawsuits allege the device gave dangerously wrong readings, leading to serious medical events.

Dexcom Inc. is a publicly traded medical device company based in San Diego, California. The G7 received FDA 510(k) clearance and hit the U.S. market as the next generation of real-time glucose monitoring for diabetic patients.

The problem? The device didn’t always work as promised. Reports of sensors failing mid-use, readings being off by significant margins, and total signal dropouts stacked up fast.

The lawsuits claim Dexcom knew about these problems and either failed to fix them or failed to warn patients and doctors. That’s a textbook product liability case.

Patients trusted this device with their lives. When it failed, some ended up in the emergency room. Others suffered permanent harm. The legal claims center on the idea that Dexcom had a duty to deliver a safe, accurate product and didn’t meet that standard.

Dexcom G7 Lawsuit Update 2026

As of 2026, lawsuits against Dexcom over the G7 are actively being filed across multiple federal courts. Attorneys are working to consolidate many of these individual cases into multidistrict litigation (MDL) to streamline the process.

The Judicial Panel on Multidistrict Litigation (JPML) has been petitioned to group these cases. If the JPML grants the request, all federal Dexcom G7 lawsuits would move to a single district court under one judge. This is the same approach used in major mass tort cases involving medical devices like hip implants and hernia mesh.

Here’s what happened leading up to 2026:

• 2023: Dexcom G7 launches widely in the U.S. market after FDA clearance.
• 2024: Adverse event reports begin stacking up in the FDA’s MAUDE database. FDA issues safety communications.
• 2025: First wave of individual lawsuits filed. FDA warning letters issued. Recall actions taken on specific lot numbers.
• 2026: Case volume increases. Attorneys push for MDL consolidation. Bellwether trial scheduling under discussion.

No bellwether trials have taken place yet. Those are the test cases that help both sides gauge how juries might respond. If MDL consolidation goes through in 2026, bellwether trials could begin in late 2026 or early 2027.

Right now, law firms across the country are still accepting new clients. The litigation is in its growth phase, which means the window to file is wide open. That won’t last forever.

Dexcom G7 Class Action Lawsuit

A Dexcom G7 class action lawsuit would group all affected users into one case with a single outcome. However, most Dexcom G7 legal claims are heading toward mass tort litigation, not a traditional class action.

There’s a big difference between the two, and it matters for your case.

Think of it this way: a class action is like everyone getting an equal slice of the same pie. A mass tort is like each person getting a slice sized to match their injury.

Because the Dexcom G7 caused varying levels of harm (some people had minor scares, others were hospitalized, some died), mass tort makes more sense. Each plaintiff’s case stands on its own facts.

That said, some consumer-focused class action claims may still emerge. These would target financial harm, like the cost of replacing faulty sensors or the price premium paid for a device that didn’t perform as advertised.

If you suffered physical injury, a mass tort claim is your stronger path.

Key Takeaway: The Dexcom G7 lawsuit is growing fast in 2026, with MDL consolidation likely, and most claims are heading toward mass tort rather than class action because individual injuries vary widely.

Dexcom G7 FDA Warning Letter Explained

An FDA warning letter is a formal notice the agency sends to a company when it finds serious violations of federal regulations. The FDA has issued warnings to Dexcom related to manufacturing and quality control problems with its glucose monitoring products.

These letters aren’t suggestions. They carry real weight. When the FDA sends a warning letter, it means inspectors found issues during facility inspections that could put patients at risk.

For Dexcom, the concerns centered on:

• Quality system violations at manufacturing facilities
• Failure to properly investigate complaints about device malfunctions
• Inadequate corrective and preventive action (CAPA) procedures
• Incomplete device history records for certain production lots

The FDA’s inspection findings suggest that Dexcom’s internal quality controls weren’t catching problems before devices reached patients. When a company ships glucose monitors that diabetic patients use to dose insulin, quality failures aren’t just paperwork problems. They’re life-or-death problems.

These warning letters are public record. They form a critical piece of evidence in the lawsuits because they show the FDA itself found problems with how Dexcom was making and monitoring its devices.

In legal terms, an FDA warning letter helps establish that Dexcom was on notice about problems. That makes it harder for the company to argue it didn’t know about the risks.

Dexcom G7 Recall History

The Dexcom G7 has been subject to multiple FDA recall actions covering specific sensor lots and transmitter units. These recalls confirm that certain G7 devices posed a real risk to patient safety.

Not all recalls are the same. The FDA classifies them by severity:

Key recall details include:

• Sensor adhesion failures causing sensors to fall off mid-wear, leaving patients without glucose data
• Transmitter communication errors where Bluetooth connections dropped, resulting in gaps in monitoring
• Inaccurate calibration in specific production lots that led to readings being consistently too high or too low
• App software glitches that displayed incorrect glucose values or failed to trigger critical low-glucose alarms

When a glucose monitor is recalled because it might give wrong numbers, that’s like recalling a car’s speedometer that shows 30 mph when you’re actually going 80. The information you’re relying on to make split-second decisions is simply wrong.

Dexcom issued voluntary recalls for some of these issues. The FDA also initiated its own enforcement actions for others. Both types of recall feed directly into the lawsuit claims, because they demonstrate the product was defective.

Dexcom G7 Sensor Failure Lawsuit

The Dexcom G7 sensor failure lawsuit targets cases where the device’s sensor simply stopped working, giving patients no glucose data at all. A dead sensor on a diabetic patient’s arm is more than an inconvenience. It’s a medical emergency waiting to happen.

Sensors are supposed to last 10 days per the G7’s design. Patients reported sensors failing within hours of application. Others experienced intermittent dropouts where the sensor would read “signal loss” for extended periods.

Here’s what sensor failure looks like in practice:

• Patient applies a new G7 sensor
• Sensor pairs with the smartphone app
• Within hours or days, the sensor stops transmitting data
• Patient has no real-time glucose information
• Without data, the patient can’t accurately dose insulin
• Risk of severe hypoglycemia (dangerously low blood sugar) or hyperglycemia (dangerously high blood sugar) spikes

The lawsuits argue that Dexcom’s sensors had a manufacturing defect that caused premature failure in certain lots. Plaintiffs say the company’s quality testing should have caught these defects before the sensors were shipped.

For patients who manage Type 1 diabetes with insulin pumps that integrate with the G7, a sensor failure can trigger a chain reaction. The pump may stop adjusting insulin delivery, leaving the patient’s blood sugar uncontrolled.

Key Takeaway: FDA warning letters and recall actions provide strong evidence for lawsuits, and sensor failures represent one of the most dangerous and well-documented defects in the Dexcom G7 system.

Dexcom G7 Inaccurate Readings Lawsuit

The Dexcom G7 inaccurate readings lawsuit focuses on cases where the device displayed glucose numbers that didn’t match the patient’s actual blood sugar level. Wrong readings led patients to make wrong decisions about insulin, food, and activity.

This is arguably the most dangerous type of malfunction. A sensor that dies at least tells you it’s dead. A sensor that lies to you is worse.

Imagine checking your G7 and seeing a blood sugar of 180 mg/dL. You take corrective insulin to bring it down. But your actual blood sugar was 90 mg/dL. That insulin dose could push you into severe hypoglycemia, which can cause seizures, loss of consciousness, or death.

Reports filed with the FDA’s MAUDE database describe exactly this scenario, repeated across hundreds of patients.

The accuracy problems fell into two main patterns:

• Consistently high readings: The device showed blood sugar higher than reality, causing patients to take unnecessary insulin
• Consistently low readings: The device showed blood sugar lower than reality, causing patients to skip needed insulin doses or eat excess carbohydrates

Plaintiffs allege that Dexcom marketed the G7 as having a MARD (Mean Absolute Relative Difference) of 8.2%, which would make it one of the most accurate CGMs on the market. The lawsuits claim real-world performance didn’t match those clinical trial numbers.

Dexcom G7 Malfunctions Reported

Dexcom G7 malfunctions extend beyond sensor failures and inaccurate readings. Users have reported a range of hardware and software problems that compromised the device’s reliability as a medical tool.

The G7 system has three main components: the sensor, the transmitter (built into the sensor for the G7), and the smartphone app or receiver. Problems have been reported with all three.

Commonly reported malfunctions include:

• App crashes during critical low-glucose alarms, silencing the alert
• Bluetooth pairing failures between the sensor and phone
• Sensor applicator malfunctions that damaged the sensor during insertion
• Display errors showing nonsensical numbers or blank screens
• Alarm system failures where urgent low or urgent high alerts never triggered
• Compatibility issues with certain phone models causing data loss

The alarm failures are especially alarming. Many patients rely on the G7’s nighttime alarms to wake them if blood sugar drops dangerously low during sleep. A condition called nocturnal hypoglycemia can be fatal if the patient isn’t awakened.

Each of these malfunctions is documented in the FDA’s public databases. They form the factual backbone of the lawsuits and show a pattern of problems, not isolated incidents.

Dexcom Continuous Glucose Monitor Problems

Dexcom continuous glucose monitor problems are not limited to the G7. The company’s track record with earlier models, including the Dexcom G6, shows a recurring pattern of device issues that plaintiffs say Dexcom never fully resolved.

The G6, which preceded the G7, had its own wave of complaints: sensor errors, inaccurate readings, and adhesive failures. When Dexcom launched the G7, patients expected these problems to be fixed. Many weren’t.

This pattern matters for the lawsuits. If Dexcom knew about sensor accuracy problems from the G6 and released the G7 without adequately addressing them, that strengthens the legal argument of negligence and failure to warn.

Worth reading: Graystad Weather Lawsuit 2026: Settlement and Filing Guide

The comparison tells a story. It suggests these weren’t random glitches that slipped through. They were systemic issues baked into how Dexcom designed, manufactured, and tested its products.

Patients switching from the G6 to the G7 expected an upgrade. Some feel they got the same problems in a sleeker package. That frustration is driving many of the lawsuits.

Key Takeaway: Inaccurate readings are the deadliest Dexcom G7 defect, malfunctions span hardware and software, and a comparison with the G6 reveals a troubling pattern of recurring issues Dexcom failed to fix.

Dexcom G7 Adverse Events

Dexcom G7 adverse events are injuries, malfunctions, or deaths reported to the FDA through the MAUDE database. The number of adverse event reports tied to the G7 has climbed sharply since the device launched.

The MAUDE (Manufacturer and User Facility Device Experience) database is a public repository where manufacturers, healthcare providers, and patients can report problems with medical devices. Every report becomes part of the public record.

As of early 2026, thousands of adverse event reports have been filed for the Dexcom G7. These reports describe:

• Severe hypoglycemic episodes requiring emergency treatment
• Hospitalizations due to diabetic ketoacidosis (DKA)
• Loss of consciousness attributed to inaccurate glucose readings
• Seizures triggered by undetected low blood sugar
• At least several reports involving patient death

It’s worth understanding that a MAUDE report doesn’t automatically prove the device caused the harm. But the sheer volume of reports tells regulators and courts that something is wrong. When you see the same type of injury reported hundreds of times, it stops looking like bad luck.

For lawyers building these cases, MAUDE data is essential evidence. It documents the scale of the problem and gives each plaintiff’s story context within a larger pattern.

Dexcom G7 Injuries Reported to the FDA

The injuries reported to the FDA in connection with the Dexcom G7 range from mild to catastrophic. Patients have suffered real physical harm because the device they trusted gave them bad information.

The most commonly reported injuries include:

• Severe hypoglycemia: Blood sugar dropping to dangerous levels (below 54 mg/dL) without the device alerting the patient
• Diabetic ketoacidosis (DKA): A life-threatening condition caused by uncontrolled high blood sugar, triggered when the device showed falsely normal readings
• Seizures: Caused by prolonged undetected hypoglycemia
• Falls and accidents: Patients losing consciousness during daily activities due to undetected blood sugar crashes
• Cognitive impairment: Repeated hypoglycemic events causing lasting brain damage
• Skin infections and allergic reactions: From defective sensor adhesive causing open wounds

These aren’t theoretical risks. Real people ended up in emergency rooms. Some spent days in intensive care units. Others suffered permanent harm that changed how they live.

Each injury strengthens the legal case against Dexcom because it ties a specific defect to a specific harm suffered by a real person. That cause-and-effect connection is the foundation of product liability law.

Dexcom G7 Hypoglycemia Injuries

Dexcom G7 hypoglycemia injuries are the most frequently cited harm in these lawsuits. Hypoglycemia occurs when blood sugar drops below safe levels, and when a CGM fails to detect or report that drop, the consequences can be severe or fatal.

Here’s how it happens with a faulty G7:

1. The G7 sensor reads blood sugar as normal or high
2. The patient sees no cause for concern
3. Actual blood sugar is plummeting
4. No alarm triggers because the device thinks everything is fine
5. Patient enters a hypoglycemic state without warning
6. If alone or asleep, the patient may lose consciousness

Below 54 mg/dL is considered serious hypoglycemia. Below 40 mg/dL can cause seizures, coma, and death. For patients with hypoglycemia unawareness (a condition where they don’t feel the symptoms of low blood sugar), the G7 was supposed to be their safety net. When it failed, they had nothing.

The lawsuits argue that Dexcom specifically marketed the G7 as a reliable tool for preventing exactly these events. When the device failed at its primary job, patients paid the price with their health.

Key Takeaway: Adverse event and injury reports in the thousands fill the FDA’s MAUDE database, with hypoglycemia injuries being the most common and most dangerous harm caused by the Dexcom G7’s failures.

Dexcom G7 Wrongful Death Claims

Dexcom G7 wrongful death claims are filed by the families of patients who died after the device allegedly failed to properly monitor glucose levels. These are the most serious cases in the litigation.

A wrongful death claim says that the patient would still be alive if the Dexcom G7 had worked correctly. These claims seek compensation for the family’s loss, including funeral costs, lost income, pain and suffering, and loss of companionship.

Several MAUDE reports reference patient deaths associated with the Dexcom G7. While investigations are still ongoing in many of these cases, the common thread is undetected hypoglycemia. The device either gave a false reading or failed to trigger its urgent low alarm.

Wrongful death cases carry the highest potential damages. They also attract the most attention from juries.

Families pursuing these claims often have strong medical records showing the patient relied on the G7 as their primary glucose monitoring tool. Autopsy reports and emergency medical records help establish the link between the device failure and the death.

These cases typically settle for higher amounts than injury-only cases because of the severity of the harm.

Who Qualifies to File a Dexcom G7 Lawsuit

You may qualify to file a Dexcom G7 lawsuit if you used the G7 continuous glucose monitor and experienced a health problem linked to a device malfunction, inaccurate reading, or sensor failure.

The general eligibility criteria are:

• You used a Dexcom G7 CGM (not a different brand or model)
• The device malfunctioned, gave inaccurate readings, or failed during use
• You suffered a measurable injury or harm as a result
• You have medical records documenting the injury and/or device failure
• Your claim falls within the applicable statute of limitations

Not everyone who used a G7 will qualify. You need to show that something went wrong with the device and that the malfunction caused you harm. Annoyance or inconvenience alone typically isn’t enough for a personal injury claim.

If you used the G6 and experienced similar problems, you may have a separate claim. Talk to an attorney about your specific situation. Each case is evaluated on its own facts.

Dexcom G7 Lawsuit Eligibility Requirements

Dexcom G7 lawsuit eligibility requires three core elements: you used the device, the device failed, and you were harmed. Each element needs supporting evidence.

Here’s a closer look at each requirement:

1. Proof of Device Use

• Prescription records showing you were prescribed the Dexcom G7
• Pharmacy or medical supply receipts
• Insurance billing records for G7 sensors and transmitters
• App data from the Dexcom G7 smartphone application

2. Proof of Device Failure

• Screenshots of error messages or inaccurate readings
• Dexcom customer service complaint records
• The physical device itself (if you still have the failed sensor)
• Correspondence with Dexcom about a malfunction

3. Proof of Injury

• Emergency room records
• Hospital admission records
• Lab results showing hypoglycemia or DKA at time of incident
• Doctor’s notes linking your condition to the device failure
• Ambulance or EMS records

Start gathering this evidence now if you think you have a case. Medical records can take weeks to obtain, and digital app data can be lost if you switch phones or delete the app.

Key Takeaway: You qualify if you used the G7, the device failed, and you were harmed; wrongful death claims carry the highest potential damages; and gathering medical records and device data early strengthens your case significantly.

How to File a Dexcom G7 Lawsuit

To file a Dexcom G7 lawsuit, contact a product liability attorney who handles medical device cases. Most attorneys take these cases on a contingency fee basis, meaning you pay nothing upfront.

Here’s the step-by-step process:

Step 1: Find a Qualified Attorney
Look for a law firm that specifically handles medical device litigation. They should have experience with CGM or glucose monitor cases. Many firms offer free initial consultations.

Step 2: Share Your Story
Tell the attorney what happened. When did the device malfunction? What injury did you suffer? What medical treatment did you receive? Be specific and honest.

Step 3: Evidence Gathering
Your attorney will help you collect medical records, device data, pharmacy records, and any communications with Dexcom. This phase can take a few weeks.

This is also helpful — Unilever Lawsuit 2026: Unauthorized Image Use Settlement

Step 4: Case Evaluation
The attorney evaluates whether your case meets the legal threshold for a product liability claim. Not every case moves forward, but strong cases with clear injuries and documented device failures typically do.

Step 5: Filing the Complaint
Your attorney files a formal legal complaint in the appropriate court. The complaint outlines what happened, why Dexcom is responsible, and what compensation you’re seeking.

Step 6: Litigation Process
Once filed, your case enters the litigation phase. This includes discovery (both sides exchange evidence), depositions, and potentially trial or settlement negotiations.

You won’t need to go to court in most cases. The vast majority of medical device lawsuits settle before trial.

Dexcom G7 Lawsuit Deadline in 2026

The Dexcom G7 lawsuit deadline depends on your state’s statute of limitations for product liability and personal injury claims. Most states give you 2 to 3 years from the date of injury to file.

This is one of the most important details in the entire case. Miss your deadline, and your claim is gone. No exceptions.

The discovery rule is important here. Some patients didn’t immediately connect their health emergency to a G7 malfunction. The discovery rule says the clock starts when you reasonably should have learned the device caused your injury.

If your G7 incident happened in 2023 or 2024, you may be approaching your deadline right now in states with a 2-year statute. Don’t wait. Contact an attorney in 2026 while your options are still open.

For wrongful death claims, the deadline is usually measured from the date of death, not the date of the device failure. Family members should act quickly.

Dexcom G7 Settlement Amounts

Dexcom G7 settlement amounts have not been finalized yet because the litigation is still in its early stages in 2026. However, based on comparable medical device lawsuits, attorneys are projecting a range of potential payouts.

No global settlement has been reached. Individual settlements may occur as cases progress, but large-scale resolution typically comes after bellwether trials establish the value of the claims.

Here are projected settlement ranges based on injury severity and comparable cases:

These are estimates based on outcomes from similar cases involving defective medical devices like insulin pumps, pacemakers, and other glucose monitors. Actual Dexcom G7 settlements could be higher or lower.

Factors that affect your individual payout include:

• Severity of your injury
• Strength of your medical records
• Direct link between the G7 malfunction and your harm
• Your age and overall health
• Your state’s damage caps (if any)
• Whether Dexcom’s conduct was especially reckless (potential punitive damages)

If bellwether trials go badly for Dexcom, settlement values tend to increase. If Dexcom wins early trials, values may decrease.

Key Takeaway: Filing deadlines vary by state but most fall between 2 and 3 years from injury; settlements haven’t been finalized yet but projections range from $5,000 for minor injuries up to $5 million or more for wrongful death based on comparable medical device cases.

Frequently Asked Questions

What is the Dexcom G7 FDA warning lawsuit about?

The lawsuit targets Dexcom Inc. for manufacturing and selling a glucose monitor that gave inaccurate readings and failed during use.

The FDA issued warning letters to Dexcom over quality control violations at its facilities.

Patients who were injured because the device malfunctioned are now filing legal claims for compensation.

How much money can I get from a Dexcom G7 settlement?

Settlement amounts depend on how badly you were hurt, ranging from $5,000 for minor incidents to over $5 million for wrongful death.

No global settlement has been reached yet as of 2026.

Attorneys project payouts based on the severity of injury and strength of evidence in each individual case.

Who qualifies to file a Dexcom G7 lawsuit in 2026?

You qualify if you used the Dexcom G7, the device malfunctioned or gave inaccurate readings, and you suffered a health injury as a result.

Medical records and proof of device use are required.

Both living patients and families of those who died may file claims.

What is the deadline to file a Dexcom G7 lawsuit?

Most states set a 2 to 3 year statute of limitations from the date of injury.

If your injury happened in 2024, your deadline could be as soon as 2026 depending on your state.

Contact an attorney now to confirm your specific filing window.

Has the Dexcom G7 been recalled by the FDA?

Yes, the FDA has issued multiple recalls for specific Dexcom G7 sensor lots and related components.

Some recalls were classified as Class I (most serious) and Class II.

Recalls targeted sensor accuracy issues, adhesive failures, and alarm system malfunctions.

If you used a Dexcom G7 and something went wrong, 2026 may be the year that defines your legal options. The lawsuits are active. Attorneys are filing cases right now. The window is open, but statutes of limitations are ticking.

Gather your medical records, save your device data, and reach out to a product liability attorney for a free case review.

Your health problem deserves a real answer. Your case deserves a real evaluation.

A related guide: Major Pandemic Lawsuit 2026: Settlement and Filing Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.